Servier’s ASCO 2025 data: Advancing IDH-mutated cancer treat...

At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.

Breaking barriers to CAR T-cell therapy: The vision for expa...

Live from ASCO 2025: Prof. Dr Jason Westin discusses CAR-T Vision, patient access, and the push to expand therapy reach in rare blood cancers.

Live from ASCO 2025: Boehringer Ingelheim on unmet needs and...

Regeneron at ASCO 25: Advancing multiple myeloma treatment

Disrupting cancer cell division: How tumour treating fields ...

Discover how Tumour Treating Fields are transforming pancreatic cancer treatment with insights from Dr. Vincent Picozzi at ASCO 2025.

Supercharging clinical trials with data and AI: Realyze’s Aa...

At ASCO 2025, Realyze CEO Aaron Brauser talks transforming clinical trial screening with AI, NLP and real-world data use.